Navigation Links
IntegriChain® Announces Release of DNA 2.0
Date:6/12/2012

PRINCETON, N.J., June 12, 2012 /PRNewswire/ -- IntegriChain, Inc., the developer of the DNA channel data and application cloud, announced today the release of DNA 2.0.  As the latest version of the company's flagship product, DNA 2.0 provides customers a next-generation suite of interactive analytics, point-of-sale reporting and real-time demand sensing.

(Logo: http://photos.prnewswire.com/prnh/20111130/NY15137LOGO )

Channel visibility is a major focus of the DNA 2.0 release, enabling users to access factory sales, wholesale inventory, retail inventory, retail stocking and point-of-sale purchases in a single integrated reporting and analytics tool.  Another enhancement provides users with real-time email notifications and exception dashboards for a growing range of order, distributor, and downstream channel metrics.

DNA 2.0 also includes major enhancements to the DNA cloud's infrastructure, greatly boosting speed and flexibility.  With the implementation of InfoBright® (a columnar database technology), and Dell™ Everest servers (which contain Intel®'s next-generation of processors), DNA 2.0 users can request, pivot and report on millions of channel data records in seconds.

Kevin Leininger, CEO of IntegriChain, stated, "Pre-canned reports are simply too limiting.  Healthcare manufacturers are more and more analytical.  They need to access their channel data in a way that is flexible and scales across large portfolios of SKUs and hundreds of thousands of points of sale.  DNA users can pull years of detailed inventory and distribution sales data in seconds, and spin and drill into this data without advanced technical knowledge."

DNA 2.0 also includes the industry's most robust process for detecting and investigating accuracy and completeness issues in EDI 852 and EDI 867 data — including real-time monitoring of inventory and sales data validity, file timeliness, and file completeness.

"DNA 2.0 is the first system to fully realize our customers' vision for complete, timely visibility to the forward channel," added Josh Halpern, IntegriChain VP of Marketing.  "By raising the industry standard for data quality, system performance, and ease of use, DNA is helping more and more manufacturers to put channel data at the heart of their customer and operational strategies."

About IntegriChain
IntegriChain, Inc. is the developer of DNA, the leading enterprise cloud for real-time channel data and analytic applications.  DNA data and apps provide manufacturers 100% visibility to their forward channels with unprecedented ease of use, speed and transparency.  DNA's end-to-end platform and self-service analytics eliminate the IT bottleneck between business users and their data, thereby accelerating enterprise decision-making.  Located in Princeton, New Jersey, IntegriChain has been recognized on both the Inc 500 and the Red Herring 100 lists of America's Fastest Growing Companies, and is nineteenth on the Forbes 2011 list of America's Most Promising Companies. For more information, please visit www.integrichain.com

All names referred to are trademarks or registered trademarks of their respective owners.

Contact: Ally Hanlon
IntegriChain, Inc.
Phone: 609.986.2004
Fax: 609.806.5006
info@integrichain.com


'/>"/>
SOURCE IntegriChain, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American HealthTech Announces Streamlined Connectivity With LTC Trend Tracker
2. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
3. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
4. Forum Extended Care Services Announces Plans to Move to Larger, State-Of-the-art Facility
5. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
6. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
7. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
8. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
9. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... 2016 Los innovadores de ... mundo, introduce catéteres para la intervención de extremidades ... compañía global especializada en el suministro de soluciones ... cartera incluyendo productos para tratar la enfermedad arterial ... son los dispositivos de primera entrada de la ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):